A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors
Henry C. Pilot, Alex A. Adjei, Joel M. Reid, Jeff A. Sloan, Pamela J. Atherton, Joseph Rubin, Steven R. Alberts, Barbara A. Duncan, Louis Denis, Larry J. Schaaf, Donghua Yin, Amarnath Sharma, Patrick McGovren, Langdon L. Miller, Charles Erlichman
Dive into the research topics of 'A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors'. Together they form a unique fingerprint.